跳到主要內容

很遺憾,我們無法支援你的瀏覽器。如果可以,請升級到新版本,或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級,而且需要支援,請將你的回饋寄給我們。

我們衷心感謝你對這個新體驗的回饋。告訴我們你的想法 打開新的分頁/視窗

Elsevier
與我們共同出版

Profile

Baik-Lin Seong

BS

Baik-Lin Seong

Yonsei University, Republic of Korea

Baik-Lin Seong, PhD, is Professor of Yonsei University College of Medicine, and Director General of Vaccine Innovative Technology ALliance (VITAL)-Korea. He served as a member of the Presidential Advisory Council of Science & Technology of Korean Government (2021-2022) and the Scientific Advisory Board of International Vaccine Institute (IVI) (2018-2022). He was the chair of the COVID-19 Vaccine Pan-Government Strategic Plan of Korean Government. With a view to ensure equitable access of effective vaccines to LMICs, he works on developing a low-cost bacterial production of VLP/nanoparticle vaccines against RSV, norovirus, highly pathogenic avian influenza, and flaviviruses including Japanese Encephalitis, Zika, and West Nile viruses